We are very excited and honored to be included in the first selection of La French Tech 2030, France's most promising companies. The cohort will benefit from extraordinary financial and extra-financial support from the French Government.
This support will allow us to successfully industrialize our product to contribute to improving access and reliability of surgical care worldwide.
It will also support us in our go-to-market strategy and reaching significant clinical, regulatory, industrial and commercial milestones.
We are very grateful to all of our intitutionnal supporters, from the Secrétariat général pour l'investissement, the Agence de l'innovation en santé, Medicen Paris Region, our incubators Agoranov and Paris Biotech Santé, of course Bpifrance, a strong supporter from the start, as well as and EIC accelerator.
We are also very happy to see lots of our friends in the selection : we're in great company !
